- Home
- BCLI vs ADGM Comparison
BCLI vs ADGM Comparison
Compare BCLI & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCLI
- ADGM
- Stock Information
- Founded
- BCLI 2000
- ADGM 2011
- Country
- BCLI United States
- ADGM United States
- Employees
- BCLI N/A
- ADGM N/A
- Industry
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- ADGM
- Sector
- BCLI Health Care
- ADGM
- Exchange
- BCLI Nasdaq
- ADGM NYSE
- Market Cap
- BCLI 13.5M
- ADGM 12.7M
- IPO Year
- BCLI N/A
- ADGM N/A
- Fundamental
- Price
- BCLI $1.89
- ADGM $0.77
- Analyst Decision
- BCLI Strong Buy
- ADGM
- Analyst Count
- BCLI 1
- ADGM 0
- Target Price
- BCLI $30.00
- ADGM N/A
- AVG Volume (30 Days)
- BCLI 109.6K
- ADGM 1.2M
- Earning Date
- BCLI 11-14-2024
- ADGM 02-15-2025
- Dividend Yield
- BCLI N/A
- ADGM N/A
- EPS Growth
- BCLI N/A
- ADGM N/A
- EPS
- BCLI N/A
- ADGM N/A
- Revenue
- BCLI N/A
- ADGM $543,000.00
- Revenue This Year
- BCLI N/A
- ADGM N/A
- Revenue Next Year
- BCLI N/A
- ADGM N/A
- P/E Ratio
- BCLI N/A
- ADGM N/A
- Revenue Growth
- BCLI N/A
- ADGM 187.30
- 52 Week Low
- BCLI $1.05
- ADGM $0.75
- 52 Week High
- BCLI $11.85
- ADGM $9.34
- Technical
- Relative Strength Index (RSI)
- BCLI 44.80
- ADGM N/A
- Support Level
- BCLI $1.90
- ADGM N/A
- Resistance Level
- BCLI $2.17
- ADGM N/A
- Average True Range (ATR)
- BCLI 0.18
- ADGM 0.00
- MACD
- BCLI -0.05
- ADGM 0.00
- Stochastic Oscillator
- BCLI 4.76
- ADGM 0.00
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
About ADGM ADAGIO MEDICAL HOLDINGS INC
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.